CR Sanjiu Medical & Pharmaceutical Company Limited, a subsidiary of China Resources Pharmaceutical Group Ltd., focuses on the manufacturing and sales of pharmaceutical products and health-related services. As an indirect non-wholly owned subsidiary, CR Sanjiu is 63.02% owned by China Resources Pharmaceutical Group Ltd. The company is listed on the Shenzhen Stock Exchange under the stock code 000999. Through its comprehensive operations, CR Sanjiu continues to play a significant role within the Group's core business, which includes research and development, manufacturing, distribution, and retail of pharmaceutical and healthcare products.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.